Victory Capital Management’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-473
| Closed | -$4.72K | – | 2494 |
|
|
2024
Q3 | $4.72K | Sell |
473
-5
| -1% | -$75 | ﹤0.01% | 2481 |
|
|
2024
Q2 | $10.7K | Buy |
+478
| New | +$14.8K | ﹤0.01% | 2464 |
|
|
2023
Q2 | – | Sell |
-2,279
| Closed | -$1.06M | – | 2549 |
|
|
2023
Q1 | $1.06M | Buy |
2,279
+267
| +13% | +$141K | ﹤0.01% | 1662 |
|
|
2022
Q4 | $806K | Buy |
2,012
+251
| +14% | +$96.1K | ﹤0.01% | 1835 |
|
|
2022
Q3 | $573K | Buy |
+1,761
| New | +$567K | ﹤0.01% | 1980 |
|
|
2022
Q1 | – | Sell |
-405
| Closed | -$143K | – | 2751 |
|
|
2021
Q4 | $143K | Sell |
405
-6
| -1% | -$1.87K | ﹤0.01% | 2527 |
|
|
2021
Q3 | $105K | Buy |
411
+10
| +2% | +$3.54K | ﹤0.01% | 2608 |
|
|
2021
Q2 | $267K | Sell |
401
-19
| -5% | -$10.9K | ﹤0.01% | 2452 |
|
|
2021
Q1 | $364K | Sell |
420
-25
| -6% | -$26.6K | ﹤0.01% | 2336 |
|
|
2020
Q4 | $413K | Buy |
445
+20
| +5% | +$21K | ﹤0.01% | 2164 |
|
|
2020
Q3 | $437K | Sell |
425
-6
| -1% | -$6.46K | ﹤0.01% | 2011 |
|
|
2020
Q2 | $437K | Sell |
431
-508
| -54% | -$472K | ﹤0.01% | 2028 |
|
|
2020
Q1 | $816K | Buy |
939
+421
| +81% | +$419K | ﹤0.01% | 1924 |
|
|
2019
Q4 | $555K | Buy |
518
+46
| +10% | +$47K | ﹤0.01% | 1962 |
|
|
2019
Q3 | $436K | Buy |
472
+390
| +476% | +$428K | ﹤0.01% | 1946 |
|
|
2019
Q2 | $92K | Sell |
82
-156
| -66% | -$171K | ﹤0.01% | 1645 |
|
|
2019
Q1 | $324K | Sell |
238
-212
| -47% | -$288K | ﹤0.01% | 1436 |
|
|
2018
Q4 | $521K | Buy |
+450
| New | +$506K | ﹤0.01% | 1351 |
|
|
2018
Q2 | – | Sell |
-450
| Closed | -$520K | – | 1834 |
|
|
2018
Q1 | $520K | Hold |
450
| – | – | ﹤0.01% | 1347 |
|
|
2017
Q4 | $534K | Hold |
450
| – | – | ﹤0.01% | 1317 |
|
|
2017
Q3 | $606K | Buy |
+450
| New | +$474K | ﹤0.01% | 1310 |
|
|
2017
Q2 | – | Sell |
-128
| Closed | -$79K | – | 1817 |
|
|
2017
Q1 | $79K | Hold |
128
| – | – | ﹤0.01% | 1688 |
|
|
2016
Q4 | $70K | Hold |
128
| – | – | ﹤0.01% | 1662 |
|
|
2016
Q3 | $66K | Hold |
128
| – | – | ﹤0.01% | 1665 |
|
|
2016
Q2 | $53K | Hold |
128
| – | – | ﹤0.01% | 1503 |
|
|
2016
Q1 | $67K | Hold |
128
| – | – | ﹤0.01% | 1270 |
|
|
2015
Q4 | $95K | Buy |
128
+37
| +41% | +$24.6K | ﹤0.01% | 1367 |
|
|
2015
Q3 | $49K | Buy |
+91
| New | +$55.1K | ﹤0.01% | 1493 |
|
Other funds holding KYNB
AC
6CM
Victory Capital Management's KYNB Position: Q4 2024 in Review
Victory Capital Management sold out of Kyntra Bio (KYNB) in Q4 2024, closing a stake of 473 shares — an estimated $4.72K sold.
Victory Capital Management first reported a position in KYNB in Q3 2015 and held it in 28 quarters. The position peaked at $1.06M in Q1 2023. 68 funds tracked by Wall St. Rank hold KYNB as of Q4 2024.
- Victory Capital Management reported no remaining Kyntra Bio position as of Q4 2024 after selling out during the quarter.
- Victory Capital Management sold 473 Kyntra Bio shares in Q4 2024, an estimated $4.72K.
- Victory Capital Management first reported a position in Kyntra Bio in Q3 2015 and held it in 28 quarters.
- Victory Capital Management's Kyntra Bio position peaked at $1.06M in Q1 2023.
- 68 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2024.
Based on Victory Capital Management's 13F filing for Q4 2024, filed 6 Feb 2025.